Walder Wyss advised IPI Partners on the deal, while White & Case advised Deutsche Bank and Natixis as mandated lead arrangers and original lenders. PI Partners,...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the shareholders of Physio Clinics SA. he shareholders and founders of the Physio Clinics network have entered into a partnership with Decalia Capital...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Ludwig Raffler as CEO and seller of AIA. Planon group has acquired AIA Atelier für Informatik und Architektur GmbH, a Swiss consultancy firm...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised IMMOFONDS in this transaction. IMMOFONDS closed its acquisition of four real estates comprising of 48 apartments with 1.5 to 4.5 rooms in Lugano, thus...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal advisor to Scott Sports SA and Scott Corporations on the deal. Scott Sports SA as borrower and Scott Corporations Ltd. as...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to Helvetia on this transaction. Helvetia successfully placed a CHF 250 million senior bond tranche with maturity in 2026 and...
You must be a Standard 1 Year member to access this content.
GÖRG Partnerschaft von Rechtsanwälten mbB and Walder Wyss advised Ufenau Capital Partners on the deal. Ufenau has acquired a majority stake in Datalogue Group, a full-service...
You must be a Standard 1 Year member to access this content.
MLL Legal advised Rhystadt AG on the deal. Walder Wyss advised UBS Switzerland AG. UBS Switzerland AG as Mandated Lead Arranger, Bookrunner, Agent, Security Agent and...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised the shareholders of Actando. Walder Wyss has advised Riverside on this transaction. Red Nucleus (“RN”), the premier provider of strategic learning and development, scientific...
You must be a Standard 1 Year member to access this content.
MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
You must be a Standard 1 Year member to access this content.
